ICON Enhances Endpoint Adjudication Services for Clinical Trials

Article

Applied Clinical Trials

ICON plc, a global provider of drug development and commercialization solutions and services, announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system, to manage workflow and ensure data quality for enhanced endpoint event adjudication services.

Read the full release here.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.